JOHN DUJMOVIC: Open Payments
NPI 1013626365 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 23 payments from 12 companies in 2025. Trend: 2023 $110 · 2024 $333 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $162 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: JARDIANCE, Ozempic, AIRSUPRA, ZORYVE, INSPIRE, PREVNAR 20, Veozah, MOUNJARO.
Industry payments across NY — which companies pay providers there.
